Mereo BioPharma Group plc
MREO
$0.24
$0.00-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -30.57% | 10.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.78% | -3.75% | |||
| Operating Income | 19.78% | -1.18% | |||
| Income Before Tax | -4.66% | 51.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.66% | 51.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.66% | 51.94% | |||
| EBIT | 19.78% | -1.18% | |||
| EBITDA | 24.02% | -2.32% | |||
| EPS Basic | -4.56% | 51.97% | |||
| Normalized Basic EPS | -0.35% | 49.91% | |||
| EPS Diluted | -4.56% | 51.97% | |||
| Normalized Diluted EPS | -0.35% | 49.91% | |||
| Average Basic Shares Outstanding | 0.06% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||